Multiple Sclerosis, Relapsing-Remitting
227
23
36
135
Key Insights
Highlights
Success Rate
86% trial completion
Published Results
43 trials with published results (19%)
Research Maturity
135 completed trials (59% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 42/100
9.7%
22 terminated out of 227 trials
86.0%
-0.6% vs benchmark
26%
59 trials in Phase 3/4
32%
43 of 135 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 135 completed trials
Clinical Trials (227)
Cladribine Tablets: Collaborative Study to Evaluate Impact On Central Nervous System Biomarkers in Multiple Sclerosis
Effects of Chiropractic Care on Cytokine Levels in Multiple Sclerosis
Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy
Effects of Task-oriented Training on Functional Mobility and Fatigue in Patients With Multiple Sclerosis
Peer Support Impact on Therapeutic Adherence in Patients With Multiple Sclerosis
B Cell Tailored Ocrelizumab Versus Standard Ocrelizumab in Relapsing Remitting Multiple Sclerosis
Cognition and MRI Markers in MS Patients With Aubagio® Treatment
Safety and Efficacy of Extracorporeal Photopheresis (ECP) in the Treatment of Multiple Sclerosis
Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
RC18 in Patients With Relapsing Remitting Multiple Sclerosis：a Phase II Trial
ITAKOS - Italian Observation, Multicenter, Prospective Study of Ofatumumab in RRMS Patients
Effects of Ocrelizumab Treatment on Immune Cells in Lymph Nodes in Multiple Sclerosis
Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis
The Synergistic Effects of AIH and FES in Persons With MS
Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS
Fatigue Alleviation Through Neuromodulating Therapy in Multiple Sclerosis
Clinnova-MS: A Prospective Cohort Study of Patients With Multiple Sclerosis: A Trans-regional Digital Health Effort Unlocking the Potential of Artificial Intelligence and Data Science in Health Care
Evaluation of the Impact of Lesions of the Motor and Proprioceptive Brain and Pan-medullary Pathways on Their Clinically and Electrophysiologically Assessed Function in Multiple Sclerosis
Clinnova-MS: A Prospective Cohort Study of Patients With Multiple Sclerosis (Switzerland)
Behavioral Intervention for Physical Activity and Sexual Dysfunction in Multiple Sclerosis